The GLP-1 receptor is present on human hepatocytes and has been shown to play a direct role in decreasing hepatic steatosis in vitro by modulating components of the insulin signaling pathway (Gupta et al. 2010). The gene discussed is INS; the disease is Hepatic steatosis.